Ledger.Open graph →
SEC Form D · Amendment · filed November 17, 2021

Athos Therapeutics, Inc

Offering
$20.4M
Sold
$20.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Carl J. Mckinzie · Los Angeles, CADirectorAllan J. Pantuck · Los Angeles, CAExec · DirectorDimitrios Iliopoulos · Los Angeles, CAExec · DirectorJoel J. Cohen · Los Angeles, CADirectorChristopher M. Lonero · PLAINSBORO, NJDirectorFarooq Abbasi · NEW YORK, NYExec · DirectorLior Hod · Elmwood Park, NJExec · DirectorEdward Borkowski · Boca Raton, FLDirectorTadashi Takakura · Tokyo, M0Exec · DirectorShu Wei · Tokyo, M0DirectorTakaya Yamamoto · Tokyo, M0DirectorTomoyuki Naruke · Tokyo, M0Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗